Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

157.47 +3.56 (+2.31%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,981,089
Open 154.16
Bid (Size) 157.30 (5)
Ask (Size) 157.70 (5)
Prev. Close 153.91
Today's Range 154.16 - 159.44
52wk Range 140.68 - 169.99
Shares Outstanding 2,628,679,824
Dividend Yield 3.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government
Via The Motley Fool
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Economy Political
From $50 A Month To $1M Portfolio — Investor Shares Top 10 Holdings, Says 'Finally Reached $1M!' Thanks To Relentless Discipline
Via Benzinga

Performance

YTD
+9.3%
+9.3%
1 Month
-3.8%
-3.8%
3 Month
+6.3%
+6.3%
6 Month
-3.3%
-3.3%
1 Year
+5.6%
+5.6%

More News

Read More
Stocks That Weathered Past Recessions: Expert Shares Picks That Withstood Every Downturn
Via Benzinga
The SWAN (Sleep Well At Night) Blueprint Revealed
Via Talk Markets
Topics Stocks / Equities
3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now
Via The Motley Fool
Topics Bonds
Exposures Debt Markets
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
Via Benzinga
Topics ETFs
Where Will Eli Lilly Be in 5 Years?
Via The Motley Fool
How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock
Via Benzinga
Topics Retirement
Exposures Pension
4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market
Via The Motley Fool
Topics Earnings Government World Trade
Exposures Financial Political Tariff
This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row
Via The Motley Fool
Topics Bonds
Exposures Debt Markets
Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Healthcare Sector Update: MEDtech And Diagnostics
Via Talk Markets
Topics ETFs Stocks / Equities World Trade
Exposures Tariff
Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
Via Benzinga
Topics Government
Exposures Political
How Is The Market Feeling About Johnson & Johnson?
Via Benzinga
Johnson & Johnson's Q1 Results, FY Guidance Highlight The 'Power Of The Pharma Portfolio'
Via Benzinga
Johnson & Johnson Earnings Were More Good Than Bad—Time to Buy?
Via MarketBeat
Topics Government Intellectual Property World Trade
Exposures Intellectual Property Political Tariff
Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit
Via Benzinga
2 Under-the-Radar Consumer Staples Stocks With Big Dividends
Via MarketBeat
Topics ETFs Intellectual Property World Trade
Exposures Intellectual Property Tariff
Johnson & Johnson Skids Despite First-Quarter Beat, Sales Guidance Hike
Via Investor's Business Daily
Topics Government Stocks
Exposures Political US Equities
Johnson & Johnson’s Q1 Earnings Beat Estimates, 2025 Guidance Revised To Account For Intra-Cellular Therapies Acquisition: Retail’s Positive
Via Stocktwits
Topics Earnings Government World Trade
Exposures Financial Political Tariff
Johnson & Johnson Reports Strong Q1 Performance
Via Talk Markets
Topics Stocks / Equities
Johnson & Johnson’s (NYSE:JNJ) Q1 Sales Top Estimates, Full-Year Sales Guidance is Optimistic
Via StockStory
Topics Intellectual Property
Exposures Intellectual Property
Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8%
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q1 2025 Results
From Johnson & Johnson
Via Business Wire

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 157.47
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 04/17/25 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 413.94B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 414B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.